TY - JOUR
T1 - Invasive strategy and frailty in very elderly patients with acute coronary syndromes
AU - Llaó, Isaac
AU - Ariza-Solé, Albert
AU - Sanchís, Juan
AU - Alegre, Oriol
AU - López-Palop, Ramon
AU - Formiga, Francesc
AU - Marín, Francisco
AU - Vidán, María T.
AU - Martínez-Sellés, Manuel
AU - Sionis, Alessandro
AU - Vives-Borrás, Miguel
AU - Gómez-Hospital, Joan Antoni
AU - Gómez-Lara, Josep
AU - Roura, Gerard
AU - Díez-Villanueva, Pablo
AU - Núñez-Gil, Iván
AU - Maristany, Jaume
AU - Asmarats, Lluis
AU - Bueno, Héctor
AU - Abu-Assi, Emad
AU - Cequier, Àngel
PY - 2018/6/1
Y1 - 2018/6/1
N2 - © Europa Digital & Publishing 2018. Aims: Current guidelines recommend an early invasive strategy in patients with non-ST-segment elevation acute coronary syndromes (NSTEACS). The role of an invasive strategy in frail elderly patients remains controversial. The aim of this substudy was to assess the impact of an invasive strategy on outcomes according to the degree of frailty in these patients. Methods and results: The LONGEVO-SCA registry included unselected NSTEACS patients aged =80 years. A geriatric assessment, including frailty, was performed during hospitalisation. During the admission, we evaluated the impact of an invasive strategy on the incidence of cardiac death, reinfarction or new revascularisation at six months. From 531 patients included, 145 (27.3%) were frail. Mean age was 84.3 years. Most patients underwent an invasive strategy (407/531, 76.6%). Patients undergoing an invasive strategy were younger and had a lower proportion of frailty (23.3% vs. 40.3%, p<0.001). The incidence of cardiac events was more common in patients managed conservatively, after adjusting for confounding factors (sub-hazard ratio [sHR] 2.32, 95% confidence interval [CI]: 1.26-4.29, p=0.007). This association remained significant in non-frail patients (sHR 3.85, 95% CI: 2.13-6.95, p=0.001), but was not significant in patients with established frailty criteria (sHR 1.40, 95% CI: 0.72-2.75, p=0.325). The interaction invasive strategy-frailty was significant (p=0.032). Conclusions: An invasive strategy was independently associated with better outcomes in very elderly patients with NSTEACS. This association was different according to frailty status.
AB - © Europa Digital & Publishing 2018. Aims: Current guidelines recommend an early invasive strategy in patients with non-ST-segment elevation acute coronary syndromes (NSTEACS). The role of an invasive strategy in frail elderly patients remains controversial. The aim of this substudy was to assess the impact of an invasive strategy on outcomes according to the degree of frailty in these patients. Methods and results: The LONGEVO-SCA registry included unselected NSTEACS patients aged =80 years. A geriatric assessment, including frailty, was performed during hospitalisation. During the admission, we evaluated the impact of an invasive strategy on the incidence of cardiac death, reinfarction or new revascularisation at six months. From 531 patients included, 145 (27.3%) were frail. Mean age was 84.3 years. Most patients underwent an invasive strategy (407/531, 76.6%). Patients undergoing an invasive strategy were younger and had a lower proportion of frailty (23.3% vs. 40.3%, p<0.001). The incidence of cardiac events was more common in patients managed conservatively, after adjusting for confounding factors (sub-hazard ratio [sHR] 2.32, 95% confidence interval [CI]: 1.26-4.29, p=0.007). This association remained significant in non-frail patients (sHR 3.85, 95% CI: 2.13-6.95, p=0.001), but was not significant in patients with established frailty criteria (sHR 1.40, 95% CI: 0.72-2.75, p=0.325). The interaction invasive strategy-frailty was significant (p=0.032). Conclusions: An invasive strategy was independently associated with better outcomes in very elderly patients with NSTEACS. This association was different according to frailty status.
KW - ACS/NSTE-ACS
KW - Clinical research
KW - Elderly (>75)
U2 - 10.4244/EIJ-D-18-00099
DO - 10.4244/EIJ-D-18-00099
M3 - Article
SN - 1774-024X
VL - 14
SP - e336-e342
JO - EuroIntervention
JF - EuroIntervention
IS - 3
ER -